FDA approval based on superiority of Gazyva over standard therapy alone, as shown in Phase II NOBILITY and Phase III REGENCY data –– Gazyva is the only anti-CD20 monoclonal antibody to demonstrate a ...
Age-related macular degeneration is a common cause of vision loss, with existing treatments only able to slow its progression ...
An electronic eye implant has restored vision in people with blindness caused by age-related macular degeneration.
Multifocal intraocular lenses may offer patients with mild-to-moderate glaucoma greater spectacle independence.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback